Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma

PURPOSE: In studies of diffuse large B-cell lymphoma, positron emission tomography with [(18)F]fluorodeoxyglucose (FDG-PET) performed after two to four cycles of chemotherapy has demonstrated prognostic significance. However, some patients treated with immunochemotherapy experience a favorable long-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Moskowitz, Craig H., Schöder, Heiko, Teruya-Feldstein, Julie, Sima, Camelia, Iasonos, Alexia, Portlock, Carol S., Straus, David, Noy, Ariela, Palomba, Maria L., O'Connor, Owen A., Horwitz, Steven, Weaver, Sarah A., Meikle, Jessica L., Filippa, Daniel A., Caravelli, James F., Hamlin, Paul A., Zelenetz, Andrew D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2010
Schlagworte:
Original Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3651601/
https://ncbi.nlm.nih.gov/pubmed/20212248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.5942
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge